Items where Author is "Kaehler, K."

Conference or Workshop Item

Weichenthal, M. and Mohr, P. and Leiter-Stoeppke, U. and Ugurel, S. and Kaehler, K. and Gutzmer, R. and Pfoehler, C. and Hassel, J. C. and Nashan, D. and Terheyden, P. and Schell, B. and Utikal, J. S. and Kreuter, A. and Haferkamp, S. and Kaune, K. and Berking, C. and Debus, D. and Ulrich, J. and Dabrowski, E. and Eigentler, T. and Welzel, J. and Herbst, R. and Loquai, C. and Meier, F. and Schadendorf, D. (2021) The Effects of Brain Metastases in Melanoma Patients on anti-PD1 Antibody Therapy with Pembrolizumab. In: 31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, hybrid.

Gutzmer, R. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Duecker, P. and Gebhardt, C. and Goeppner, D. and Haferkamp, S. and Kaehler, K. and Meier, F. and Pfoehler, C. and Satzger, I. and Sickmann, T. and Sindrilaru, A. and Terheyden, P. and Ugurel, S. and Ulrich, J. and Utikal, J. and Weishaupt, C. and Schadendorf, D. (2020) Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO plus IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO. In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.

Other

Zaremba, A. and Weishaupt, C. and Glutsch, V. and Schilling, B. and Loquai, C. and Rafei-Shamsabadi, D. and Meiss, F. and Gutzmer, R. and Haferkamp, S. and Kaehler, K. and Moreira, A. and Heinzerling, L. and Thoms, K. M. and Kiecker, F. and Pfoehler, C. and Ugurel, S. and Roesch, A. and Zimmer, L. and Schadendorf, D. and Livingstone, E. (2019) Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma. WILEY, HOBOKEN.

Leiter-Stoeppke, U. and Loquai, C. and Meier, F. and Rafei-Shamsabadi, D. and Hassel, J. and Glutsch, V. and Sirokay, J. and Schlecht, N. and Ruebben, A. and Gutzmer, R. and Kaehler, K. and Gambichler, T. and Schatton, K. and Pfoehler, C. and Franklin, C. and Terheyden, P. and Haferkamp, S. and Mohr, P. and Heinzerling, L. and Meiwes, A. and Keim, U. and Becker, J. C. and Bischof, L. and Livingstone, E. and Schadendorf, D. and Ugurel, S. (2019) Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO. WILEY, HOBOKEN.

Heppt, M. and Heinzerling, L. and Kaehler, K. and Forschner, A. and Kirchberger, M. and Loquai, C. and Meissner, M. and Meier, F. and Terheyden, P. and Schell, B. and Herbst, R. and Goeppner, D. and Kiecker, F. and Rafei-Shamsabadi, D. and Haferkamp, S. and Huber, M. and Utikal, J. and Ziemer, M. and Bumeder, I and Pfeiffer, C. and Schd-Trcka, S. and Schmid-Tannwald, C. and Tietze, J. and Eigentler, T. and Berking, C. (2017) Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition. WILEY, HOBOKEN.

Livingstone, E. and Eigentler, T. and Rompel, R. and Meiss, F. and Mauerer, A. and Kaehler, K. and Dippel, E. and Moellenhoff, K. and Kilian, K. and Kretschmer, L. and Debus, D. and Windemuth-Kieselbach, C. and Hauschild, A. and Schadendorf, D. (2013) Quality Assurance Project Melanoma: Results of the final Survey 4 Years after initial Diagnosis. WILEY-BLACKWELL, HOBOKEN.